Related Experiment Video

Updated: Jul 6, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders

F Djouadi1, J Bastin

  • 1CNRS UPR 9078, Université Paris Descartes, Faculté Necker-Enfants Malades, Paris, France.

Journal of Inherited Metabolic Disease
|April 9, 2008
PubMed

Insights

Pharmacological activation of PPAR signaling may offer a new therapeutic approach for inherited metabolic disorders affecting mitochondrial fatty acid oxidation (FAO). This strategy shows promise for conditions like CPT II and VLCAD deficiencies.

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Enzyme defects in mitochondrial fatty acid oxidation (FAO) represent a significant group of inherited metabolic diseases.
  • Current pharmacological treatments for FAO disorders are limited, despite extensive clinical and genetic characterization.

Purpose of the Study:

  • To investigate the potential of pharmacological correction for FAO disorders using PPAR activators.
  • To explore the therapeutic efficacy of fibrates and other PPAR agonists in treating FAO deficiencies.

Main Methods:

  • Review of existing data on PPAR signaling pathway regulation of mitochondrial FAO genes.
  • Testing PPAR activators in cellular models derived from patients with CPT II and VLCAD deficiencies.

Main Results:

  • Demonstrated that PPAR signaling pathway regulates genes involved in mitochondrial FAO.
  • Observed positive effects of PPAR activators in cellular models of CPT II and VLCAD deficiencies.

Conclusions:

  • PPAR activators represent a promising pharmacological strategy for treating FAO disorders.
  • Further research is needed to fully understand the perspectives and limitations of this therapeutic approach.

More Related Videos

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

Related Concept Videos

Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Porin Insertion in the Outer Mitochondrial Membrane01:12

Porin Insertion in the Outer Mitochondrial Membrane

Porins are beta-barrel proteins translocated to the mitochondrial outer membrane through the TOM complex into the intermembrane space. Porin precursors bind TIM chaperones within the intermembrane space and are guided to the Sorting and Assembly Machinery complex or SAM complex on the outer mitochondrial membrane.
Three models describe the assembly of porins by the SAM complex and their insertion into the outer membrane. Model 1 suggests that porins are assembled outside the SAM channel as the...